ProCE Banner Activity

Optimizing the Use of BTK Inhibitors in B-Cell Malignancies

Slideset Download
In this downloadable slideset, Ian W. Flinn, MD, PhD, examines optimal treatment approaches with BTK inhibitors in patients with B-cell malignancies.

Released: June 05, 2019

Expiration: June 03, 2020

No longer available for credit.

Share

Faculty

Ian W. Flinn

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse